We are live on ! Find out more
BIO icon

Bio-Rad Laboratories Class A
BIO

276 hedge funds and large institutions have $4.26B invested in Bio-Rad Laboratories Class A in 2017 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 107 increasing their positions, 94 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more repeat investments, than reductions

Existing positions increased: 107 | Existing positions reduced: 94

13% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 32

12% more capital invested

Capital invested by funds: $3.8B → $4.26B (+$458M)

7% more call options, than puts

Call options by funds: $1.11M | Put options by funds: $1.04M

1% more funds holding

Funds holding: 274 → 276 (+2)

0% more funds holding in top 10

Funds holding in top 10: 10 → 10 (0)

1.07% less ownership

Funds ownership: 77.87% → 76.8% (-1.1%)

Holders
276
Holders Change
+2
Holders Change %
+0.73%
% of All Funds
6.88%
Holding in Top 10
10
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.25%
New
36
Increased
107
Reduced
94
Closed
32
Calls
$1.11M
Puts
$1.04M
Net Calls
+$68K
Net Calls Change
+$99M

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$109M
2
Wells Fargo
Wells Fargo
California
+$55.1M
3
CRM
Cramer Rosenthal McGlynn
Connecticut
+$47.6M
4
CCM
Clearfield Capital Management
New York
+$44.1M
5
Citadel Advisors
Citadel Advisors
Florida
+$35.5M

Top Sellers

1
CM
Corvex Management
New York
-$184M
2
Millennium Management
Millennium Management
New York
-$61.6M
3
ACM
Atlanta Capital Management
Georgia
-$23.4M
4
AI
Ariel Investments
Illinois
-$21.8M
5
HIM
Hermes Investment Management
United Kingdom
-$21.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
Ameriprise
51
Ameriprise
Minnesota
$15.7M +$98.1K +450 +0.7%
Assenagon Asset Management
52
Assenagon Asset Management
Luxembourg
$15M +$14.4M +66,086 New
Invesco
53
Invesco
Georgia
$14.9M -$2.33M -10,697 -14%
AQR Capital Management
54
AQR Capital Management
Connecticut
$13.3M -$85.6K -393 -0.7%
California Public Employees Retirement System
55
California Public Employees Retirement System
California
$13.2M +$131K +600 +1%
PAMP
56
Polar Asset Management Partners
Ontario, Canada
$13.1M -$1.81M -8,300 -13%
SAM
57
Sentinel Asset Management
Vermont
$13M -$1.05M -4,800 -8%
SEI Investments
58
SEI Investments
Pennsylvania
$12.9M +$1.98M +9,106 +19%
GI
59
GAMCO Investors
Connecticut
$12.3M -$131K -600 -1%
Allianz Asset Management
60
Allianz Asset Management
Germany
$11.5M +$10.6M +48,698 +2,423%
Adage Capital Partners
61
Adage Capital Partners
Massachusetts
$11.3M +$10.9M +50,022 New
TA
62
Teachers Advisors
New York
$11.1M -$938K -4,304 -8%
SIM
63
Spark Investment Management
New York
$10.7M – – –
Deutsche Bank
64
Deutsche Bank
Germany
$10.6M -$2.98M -13,669 -23%
BC
65
Beaconlight Capital
New York
$10.4M +$893K +4,100 +10%
O
66
OppenheimerFunds
New York
$10.3M +$2.9M +13,304 +42%
Prudential Financial
67
Prudential Financial
New Jersey
$9.84M +$6.58M +30,179 +227%
AIG
68
American International Group
New York
$9.63M +$219K +1,005 +2%
RhumbLine Advisers
69
RhumbLine Advisers
Massachusetts
$9.42M -$453K -2,078 -5%
GF
70
Gabelli Funds
New York
$9.32M -$654K -3,000 -7%
GIM
71
Granahan Investment Management
Massachusetts
$8.84M +$4.6M +21,091 +117%
California State Teachers Retirement System (CalSTRS)
72
California State Teachers Retirement System (CalSTRS)
California
$8.75M -$852K -3,908 -9%
TCM
73
Tygh Capital Management
Oregon
$8.02M +$972K +4,461 +14%
CS
74
Credit Suisse
Switzerland
$7.91M +$3.12M +14,335 +70%
Swiss National Bank
75
Swiss National Bank
Switzerland
$7.86M +$109K +500 +1%
1 2
3
4 5

BIO Hedge Fund Activity: Q2 2017 in Review

276 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q2 2017, worth a combined $4.26B — up 12% from $3.8B a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new BIO positions and 32 closed out — a net gain of 4 holders — while 107 added to existing stakes and 94 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $109M. The largest seller was Corvex Management, cutting an estimated $184M.

  • 276 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q2 2017, up from 274 in Q1 2017.
  • Funds reported $4.26B of Bio-Rad Laboratories Class A stock for Q2 2017, up 12% quarter-over-quarter.
  • 36 funds opened new Bio-Rad Laboratories Class A positions in Q2 2017 and 32 closed out, a net change of +4 holders.
  • The largest Bio-Rad Laboratories Class A buyer in Q2 2017 was Fidelity Investments, an estimated $109M added.
  • The largest Bio-Rad Laboratories Class A seller in Q2 2017 was Corvex Management, an estimated $184M sold.

Based on aggregated 13F filings for Q2 2017.